Cleared Special

K090013 - CHEMPAQ XBC ANALYZER

K090013 is the FDA 510(k) clearance for CHEMPAQ XBC ANALYZER by Chempaq A/S. It is a Class 2 Hematology device (product code GKZ) cleared through the Special 510(k) pathway after a 109-day FDA review.

K090013 · Chempaq A/S · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
109d
Days
Class 2
Risk

K090013 is an FDA 510(k) clearance for the CHEMPAQ XBC ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Chempaq A/S (Farum, DK). The FDA issued a Cleared decision on April 21, 2009 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Chempaq A/S devices

Submission Details

510(k) Number K090013 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 02, 2009
Decision Date April 21, 2009
Days to Decision 109 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 113d · This submission: 109d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 194
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K090013.
ADVIA 2120/2120I BODY FLUIDS
K090346 · Siemens Healthcare Diagnostics · Jul 2010
BC-3200 AUTO HEMATOLOGY ANALYZER,M-30D DILUENT, M-30R RINSE, M-30CFL LYSE, M-30E-Z CLEANSER, M-30PROBE CLEANSER, BC-3D C
K093394 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2010
THERMO SCIENTIFIC CYTO-CAL COUNT TUBES
K090810 · Microgenics Corp. · Sep 2009
CELL-DYN EMERALD SYSTEM
K081495 · Abbott Laboratories · Feb 2009
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
K081930 · Beckman Coulter, Inc. · Dec 2008
FLOWCARE TLG REAGENT
K081526 · Beckman Coulter, Inc. · Aug 2008